Evidence map›Paper›PMID 41451346›Full record

ArticleFrontiers in bioinformatics2025

Neurogenic locus notch homolog protein 1 (NOTCH 1) SNP informatics coupled with intrinsically disordered regions and post-translational modifications reveals the complex structural crosstalk of Lung Adenocarcinoma (LUAD).

Pearl John, C Sudandiradoss

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pearl JohnDepartment of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, India.
C SudandiradossDepartment of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung adenocarcinoma (LUAD) is the predominant histological subtype of lung cancer, representing a major contributor to cancer mortality rate marked by a high frequency of mutations and intricate interactions between multiple signalling pathways. Objective: Here we explore the role of NOTCH1 associated Single nucleotide polymorphisms (SNPs) IDR and PTM in LUAD progression. Although the NOTCH1 expression is downregulated, it has been validated as an important prognostic marker because of its complex biological roles under specific conditions. Methods: With the aid of In silico tools we predicted and identified the deleterious SNPs. The Molecular Docking and dynamics simulations (MDS) were conducted to characterize these mutations. Results: A total of 43 deleterious SNPs were found in the sequential SNP analysis with 13 SNPs resulted deleterious and damaging effects. The stabilizing SNPs such as S1464I, A1705V and T1602I are found within the conserved and functional domains of NOTCH1. In addition, 1660-2555 sequence region of the PEST domain was recognized as an Intrinsically Disordered Region (IDR) with a score of above 0.5. Moreover, the presence of the two phosphodegrons (SCF_FBW7_1 at 2129-2136 and SCF_FBW7_2 at 2508-2515) along with the Post Translational Modification (PTM) such as o-linked glycosylation and Phosphothreonine within the IDR region, PEST and conserved domains suggest functional significance in LUAD progression. Conclusion: In conclusion our research highlights the potential regulatory role of identified SNPs, PTMs, and the functional domains of Notch1, particularly the PEST domain and IDR, in pathophysiology of LUAD particularly through the crosstalk of the EMT signalling.

Indexed as

deleterious SNPepithelial–mesenchymal transition signalingintrinsically disordered regionlung adenocarcinomamolecular dynamics simulationneurogenic locus notch homolog protein 1post-translational modification

Identifiers

PMID41451346
PMCPMC12727990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.